May is Lyme Disease Awareness Month. As the temperatures rise and people spend more time outdoors, tick bites become more ...

This could include allergy testing, blood tests to detect inflammation markers, or tests for celiac disease or thyroid problems. If the hives are not always apparent, it may help for a person to ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

The rash rarely itches and can blend into larger patches ... close contacts of immunocompromised individuals or those with ...

Washington recorded its fifth case of the virus in 2025, as U.S. sees its biggest measles outbreak in years, with over 800 ...

Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) for chronic ...